People living with Charcot-Marie-Tooth disease are not passive recipients of care or research outcomes—they are essential partners in shaping meaningful progress.

Patients bring lived experience, long-term perspective, and practical insight that cannot be captured through clinical data alone. Their involvement strengthens research relevance, improves study design, and ensures that outcomes align with real-world needs and priorities.

ECRA actively promotes patient involvement across research, education, and advocacy initiatives. This includes participation in advisory roles, contribution to research planning, engagement in educational activities, and collaboration in shaping communication and policy priorities.

By recognizing patients as partners, ECRA supports a model of collaboration based on mutual respect, shared responsibility, and transparency. Sustainable progress in CMT research and care is only possible when scientific expertise and lived experience work together.